These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 25228541)

  • 1. NK1 receptor antagonists as a new treatment for corneal neovascularization.
    Bignami F; Giacomini C; Lorusso A; Aramini A; Rama P; Ferrari G
    Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6783-94. PubMed ID: 25228541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth inhibition of formed corneal neovascularization following Fosaprepitant treatment.
    Bignami F; Lorusso A; Rama P; Ferrari G
    Acta Ophthalmol; 2017 Nov; 95(7):e641-e648. PubMed ID: 28205389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of topical infliximab in a mouse model of ocular surface scarring.
    Ferrari G; Bignami F; Giacomini C; Franchini S; Rama P
    Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):1680-8. PubMed ID: 23404121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alkali burn versus suture-induced corneal neovascularization in C57BL/6 mice: an overview of two common animal models of corneal neovascularization.
    Giacomini C; Ferrari G; Bignami F; Rama P
    Exp Eye Res; 2014 Apr; 121():1-4. PubMed ID: 24560796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effects of zerumbone in an alkali-burned corneal wound healing model.
    Kim JW; Jeong H; Yang MS; Lim CW; Kim B
    Int Immunopharmacol; 2017 Jul; 48():126-134. PubMed ID: 28501766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of NADPH oxidases in alkali burn-induced corneal injury.
    Gu XJ; Liu X; Chen YY; Zhao Y; Xu M; Han XJ; Liu QP; Yi JL; Li JM
    Int J Mol Med; 2016 Jul; 38(1):75-82. PubMed ID: 27221536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical treatment of corneal alkali burns with Gly-thymosin β
    Zhang W; Nie L; Du L; Chen W; Wu Z; Jin Y
    Burns; 2017 Dec; 43(8):1742-1747. PubMed ID: 28602595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of RAP1 enhances corneal recovery following alkali injury.
    Poon MW; Yan L; Jiang D; Qin P; Tse HF; Wong IY; Wong DS; Tergaonkar V; Lian Q
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):711-21. PubMed ID: 25574050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of TC14012 on alkali burn-induced corneal neovascularization in mice.
    Shen M; Yuan F; Jin J; Yuan Y
    Ophthalmic Res; 2014; 52(1):17-24. PubMed ID: 24853648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone and MicroRNA-204 Inhibit Corneal Neovascularization.
    Zhang X; Wang G; Wang Q; Jiang R
    Mil Med; 2024 Jan; 189(1-2):374-378. PubMed ID: 36043264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inhibitory effect of different concentrations of KH902 eye drops on corneal neovascularization induced by alkali burn.
    Wu Y; Xue C; Lu Y; Huang Z
    Indian J Ophthalmol; 2017 Nov; 65(11):1127-1132. PubMed ID: 29133637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the effects of resveratrol and bevacizumab on experimental corneal alkali burn.
    Doganay S; Firat PG; Cankaya C; Kirimlioglu H
    Burns; 2013 Mar; 39(2):326-30. PubMed ID: 22922008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KH902, a recombinant human VEGF receptor fusion protein, reduced the level of placental growth factor in alkali burn induced-corneal neovascularization.
    Zhou AY; Bai YJ; Zhao M; Yu WZ; Li XX
    Ophthalmic Res; 2013; 50(3):180-6. PubMed ID: 24008241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained Subconjunctival Delivery of Infliximab Protects the Cornea and Retina Following Alkali Burn to the Eye.
    Zhou C; Robert MC; Kapoulea V; Lei F; Stagner AM; Jakobiec FA; Dohlman CH; Paschalis EI
    Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):96-105. PubMed ID: 28114570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of topical aflibercept versus topical bevacizumab for the prevention of corneal neovascularization in a rat model.
    Sella R; Gal-Or O; Livny E; Dachbash M; Nisgav Y; Weinberger D; Livnat T; Bahar I
    Exp Eye Res; 2016 May; 146():224-232. PubMed ID: 27020759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient downregulation of microRNA-206 protects alkali burn injury in mouse cornea by regulating connexin 43.
    Li X; Zhou H; Tang W; Guo Q; Zhang Y
    Int J Clin Exp Pathol; 2015; 8(3):2719-27. PubMed ID: 26045777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upadacitinib inhibits corneal inflammation and neovascularization by suppressing M1 macrophage infiltration in the corneal alkali burn model.
    Yu J; Shen Y; Luo J; Jin J; Li P; Feng P; Guan H
    Int Immunopharmacol; 2023 Mar; 116():109680. PubMed ID: 36739832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of nicotine on corneal wound healing following acute alkali burn.
    Kim JW; Lim CW; Kim B
    PLoS One; 2017; 12(6):e0179982. PubMed ID: 28644870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn.
    Yoeruek E; Ziemssen F; Henke-Fahle S; Tatar O; Tura A; Grisanti S; Bartz-Schmidt KU; Szurman P;
    Acta Ophthalmol; 2008 May; 86(3):322-8. PubMed ID: 17995975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of sub-conjunctival tocilizumab on alkali burn induced corneal neovascularization in rats.
    Sari ES; Yazici A; Aksit H; Yay A; Sahin G; Yildiz O; Ermis SS; Seyrek K; Yalcin B
    Curr Eye Res; 2015 Jan; 40(1):48-55. PubMed ID: 24910898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.